Mast Cell Leukemia (MCL)
specificA progressive, proliferative disease of blood cells, originating from mast cells.
14
Centers
14
Active Trials
—
Cancer Funding
Top Centers for Mast Cell Leukemia (MCL)(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 53.6 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 53.6 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 53.6 |
| 4 | NCI Comprehensive Active Research Program | 53.6 |
| 5 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 53.6 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 53.6 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 53.6 |
| 8 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 53.6 |
| 9 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 53.6 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 53.6 |
| 11 | Boston University Cancer CenterBoston, MA Active Research Program | 53.6 |
| 12 | Cancer Center at IllinoisUrbana, IL Active Research Program | 53.6 |
| 13 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 53.6 |
| 14 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 53.6 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →